NC-VERANEX
12.10.2021 15:02:07 CEST | Business Wire | Press release
Veranex , the first concept-to-commercialization global service provider dedicated to the MedTech industry, today announced the acquisition of IMMR , a leading preclinical science organization that provides preclinical research, pathology evaluation and surgical training services to medical technology innovators. IMMR is located in Paris, France.
Formed in June 2021 with global growth investor Summit Partners , Veranex provides the global medical technology industry with comprehensive and integrated solutions and services that accelerate the product life cycle to help improve the lives of patients everywhere. As a result of this acquisition, Veranex gains state-of-the-art, FDA-inspected and AAALAC-accredited facilities and extensive in-house expertise, enhancing Veranex’s services for preclinical studies worldwide.
“We are excited to welcome the world-class and market leader IMMR to Veranex,” said Patrick K. Donnelly , Executive Chairman at Veranex. “Veranex is focused on the needs of the MedTech industry and this acquisition enhances our long-term ability to meet the end-to-end needs of MedTech companies in one organization. Veranex’s clients will benefit from IMMR’s 30-plus years of experience in the design and conduct of preclinical studies, expertise in complex cardiovascular and non-cardiovascular procedures, and state-of-the-art surgical suites and husbandry facilities, all unparalleled for leading successful completion of sophisticated studies with novel interventional or surgical technologies.”
“As part of a combined company with a full range of product development, regulatory, and market access expertise, our partnership with Veranex complements our vision to help clients achieve their objectives and advance important MedTech innovations that significantly improve patient care,” said IMMR Founding Partner and Scientific Director Luc Behr , D.V.M., Ph.D. “IMMR adds another dimension of expertise and services to Veranex to enable and accelerate research in the industry.”
IMMR’s unique, highly efficient, and full service approach — with studies that are carefully planned, expertly conducted to the highest ethical standards, and professionally documented — saves money and reduces time to market.
“IMMR excels in procedures ranging from early feasibility studies through to GLP studies to support global regulatory approvals,” added IMMR Founding Partner and Scientific Director Nicolas Borenstein , D.V.M., Ph.D. “With our expert team of professionals, our worldwide clientele enjoys high success rates with their medical technology innovations.”
For this transaction, financial advisors were Clearwater International and Cain Brothers , a division of KeyBanc Capital Markets, and Gide Loyrette Nouel , a leading international law firm located in Paris, served as legal counsel. Financial terms of the transaction were not disclosed.
About Veranex
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time, while its integrated and comprehensive solutions unify the entire development process. For more information, visit VeranexSolutions.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211012005017/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Reply Introduces Symbiosis: an AI-Driven Operating Model to Align Business Priorities and AI-Accelerated Delivery14.10.2026 10:00:00 CEST | Press release
Reply [EXM, STAR: REY] introduces Symbiosis, an AI-driven operating model designed for enterprises integrating generative AI and agentic systems into their operating processes. Supported by a dedicated platform, Symbiosis connects strategy, portfolio management and execution, helping organisations align priorities and investment decisions with measurable business outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014833053/en/ Reply introduces Symbiosis, an AI-driven operating model designed for enterprises integrating generative AI and agentic systems into their operating processes. Supported by a dedicated platform, Symbiosis connects strategy, portfolio management and execution, helping organisations align priorities and investment decisions with measurable business outcomes. As AI enables teams to develop, test and deliver solutions faster, organisations also need to adapt how they decide where to focus that cap
SIAL Paris 2026: Food Sovereignty, AI, Personalised Nutrition… Three Major Debates to Shape the Future of Food14.10.2026 09:35:00 CEST | Press release
More than just a major business event, SIAL Paris is also a forum for reflection, analysis and inspiration for the entire food sector. Over five days, several stages will bring together leaders, experts, manufacturers, retailers, researchers and entrepreneurs to analyse the sector’s transformations and, above all, to identify concrete courses of action. Food sovereignty, artificial intelligence, geopolitics, new consumption models, personalised nutrition and the transformation of the value chain: the 2026 edition offers a particularly rich programme, featuring conferences, keynote speeches, round-table discussions, pitches and case studies. SIAL Summits: three major events to understand today and prepare for tomorrow At the heart of this programme, the SIAL Summits, held in Hall 5A, offer three premium 2½-hour sessions dedicated to the strategic challenges reshaping the agri-food industry. Designed as genuine platforms for discussion and reflection, they will bring together experts and
UNPACK ’27: HOTELS.COM AFSLØRER DE REJSETRENDS, DER KOMMER TIL AT PRÆGE 202714.10.2026 09:00:00 CEST | Pressemeddelelse
Ny rapport fra Hotels.com identificerer fem rejsetrends, der vil komme til at præge 2027 lige fra efterspørgslen på små svipture og en genopblomstring af gotiske destinationer til næste års prognose for set-jetting. Hotels.com har i dag offentliggjort den årlige rapport Unpack ’27: The Trends in Travel™, der undersøger de destinationer, oplevelser og adfærdsmønstre, der forventes at præge rejsebranchen i 2027. Baseret på indsigter fra Hotels.com samt global rejseresearch og social listening afslører Unpack ‘27 de nye steder, der tiltrækker rejsende i 2027, og nogle overraskende ting, de foretager sig, når de først er ankommet. “At rejse handler om at skabe minder, og Unpack ‘27 afslører de destinationer og oplevelser, der præger netop de øjeblikke”, siger Ariane Gorin, CEO for Expedia Group. “I 2027 vil rejsende være mere bevidste i valget af deres næste eventyr og søge oplevelser, der er mere personlige og meningsfulde for dem. Vi gør det nemmere at opdage, planlægge og booke den rigt
Otometrics Launches Aurical® IQ – Delivering the First and Only Guided Workflow Enabling up to 51% Faster Fittings and 39% Improved Workflow Accuracy14.10.2026 09:00:00 CEST | Press release
Clinical evaluations demonstrated up to 51% faster fitting times for experienced clinicians and 39% improved workflow accuracy for newer clinicians; Aurical IQ also supports the NAL-NL3 Fitting System Otometrics, the Hearing & Balance division of Natus Sensory, today announced Aurical® IQ, the next generation of its trusted hearing aid fitting and verification platform. Combining the first and only Guided Workflow for hearing aid fitting and verification, support for the NAL-NL3 Fitting System and a redesigned Otosuite® software experience, Aurical IQ is designed to help hearing care professionals work more efficiently and follow best-practice fitting procedures with greater consistency. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014023398/en/ Aurical IQ Guided Workflow provides structured, step-by-step guidance through the fitting and verification process, designed to make best-practice fitting easier to follow. A ne
NEURA Robotics Introduces Neuron AI: The Brain of the Physical World14.10.2026 08:29:00 CEST | Press release
Beyond vision: Neuron AI brings 3D vision, touch, audio, robot state and language together with memory in one Perception-Language-Action (PLA) model, so robots can react to what they cannot seeOne model, every body: Trained on real-world robot data, simulation-amplified data and human demonstrations, Neuron AI runs across five NEURA robot embodiments and their grippers and handsFrom skill to fleet: Customers fine-tune Neuron AI for their own tasks and deploy skills across robot fleets via the platform Neuraverse, with Time-to-Skill as the central measure of progressAI built in Germany: Developed and trained in-house in Metzingen, GermanyLive at NVIDIA GTC Berlin: NEURA’s humanoid 4NE1 will complete an eleven-minute laundry task, fully autonomous from start to finish NEURA Robotics (“NEURA”) today introduced Neuron AI, its multimodal foundation model for Physical AI. Combining 3D vision, touch, audio, robot state and language with memory, Neuron AI enables robots to act on information b
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom